Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy
Conditions
- Myocardial Infarction, Acute
- Coronary Artery Disease
Interventions
- DRUG: Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin)
- DRUG: Standard DAPT
Sponsor
MicroPort CRM
Collaborators